TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Spleen Volume Measurement Reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric mean titer (GMT) of antigen-specific binding antibody titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants Who Experienced a Post Dose 1 Seroresponse Against the H1N1 Strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants Who Experienced a Post Dose 2 Seroresponse Against the H1N1 Strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence and type of adverse events (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence and type of possibly/probably or definitely related serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Ratio of Pf positive blood smear (+BS) in experimental arm to Pf +BS in placebo arm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in Total Ventilation Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rectal cancer assessment scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Global Impression Scale - indirect
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Glasgow-Edinburgh Throat Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional Esophageal Disorder Module Interview
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Screening for somatoform disorder (SOMS-7)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change From Baseline in Mean Sitting Systolic Blood Pressure (msSBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Development of radiation pneumonitis
Endpoint domain: Adverse events/effects
Primary endpoint: Development of radiation necrosis
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence and severity of acute adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Metaphase II (MII)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Percent Change of the Sum of the Eyes, Mouth, Speech and Swallowing Subscores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Prevalence of mental stress induced ischemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of participants with an HIV-1 viral load < 50 copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-care Maintenance
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Self-care Management
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Self-care Confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Overall Quality of Lens Vision
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Overall Lens Comfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Overall Lens Handling
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Detection of lung cancer
Endpoint domain: Mortality/survival
Primary endpoint: Batting movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Polysomnographic measures of sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Polysomnographic measures of daytime sleepiness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Fatigue
Primary endpoint: Distal/proximal skin temperature gradient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of women with positive pregnancy test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Mean Change in Low Back Pain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change in Back Function Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Determined to be a Fusion Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Delayed Recall on the Name-Face Association Test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: expected disease progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: safety of IT mafosfamide
Endpoint domain: Adverse events/effects
Primary endpoint: Major adverse cardiocerebral events (MACCE)
Endpoint domain: Adverse events/effects
Primary endpoint: Septic complication in the operated limb
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Heart SMART Program survey score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Occurrence of adverse outcomes after ambulation
Endpoint domain: Adverse events/effects
Primary endpoint: Infection Rates
Endpoint domain: Adverse events/effects
Primary endpoint: ROC curve characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: platelet transfusion efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Antiretroviral Medication Adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total Bacterial Load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of Participants With Complete Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Rate of Major Hematological Improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Responsiveness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sensitivity of urinalysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of urinalysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Energy intake (total kilocalories)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Morphine milligram equivalents used from 25-72 hours post-op
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Morphine milligram equivalent usage from day of discharge to outpatient post-operative visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of joint inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: neuro-endocrine measurements composite
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: immunological measurements composite
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: cellular energy metabolism measurements composite
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Severity of Symptoms as Measured by Montgomery-Asberg Depression Rating Scale (MADRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant's Clinical Global Impression-Severity (CGI-S) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Suicidality Risk (Ideation and Attempts) as Measured by Columbia-Suicide Severity Rating Scale (C-SSRS) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of MVA85A vaccines
Endpoint domain: Adverse events/effects
Primary endpoint: Immunogenicity of MVA85A vaccines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Lyme Disease Manifestations at 14 Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-Lyme Disease Symptoms at 14 Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Acuity, High Contrast, Distance Chart
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Acuity, Low Contrast, Distance Chart
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Acuity, High Contrast, Near Chart
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Acuity, Low Contrast, Near Chart
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-degree Off-axis Distance Visual Acuity, High Contrast Chart
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-degree Off-axis Distance Visual Acuity, Low Contrast Chart
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vertical amount of bone increased (length in millimeters)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Horizontal amount of bone increased (width in millimeters)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interrater Reliability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Three-dimensional geometrical configuration of the skeleton
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to placement in seconds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: visualization time of location of injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adequacy of ropivacaine spread
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Worst numerical scale pain in the first 12 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to serum methotrexate level <0.1 micromol/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of new symptomatic venous and arterial thromboembolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Serological test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent of patients leaving on post-operative day 0
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Changes in uncorrected visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in ambulation over 24 months as measured by the 10 meter walk (m/s)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in respiratory function over 24 months as measured by spirometry, specifically the supine forced vital capacity (FVC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Quality of Life Score (generic)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of Life Score (ulcer-specific)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Immediate pretest score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes in UPDRS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of syringing attempts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the diameter of the common carotid artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Ability to reverse anticoagulant effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stool microbiome composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intersubject agreement on validation of the questions of the AKQoL
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Disease Control Rate (DCR) of Brain Metastases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Sustained return of spontaneous circulation (ROSC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time-to-event occurrence of completed sexual assault
Endpoint domain: Adverse events/effects
Primary endpoint: Reversible perfusion defects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Wound Healing Complication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of lesions with progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change from baseline in 24-h systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean change from baseline in 24-h diastolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: score of gut dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of Responders with Rise in Plasma Transaminases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Plasma Log10 Hepatitis C Virus (HCV) Ribonucleic Acid (RNA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Objective Response (Partial and Complete)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of repetitions in the 1-min STS test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease Free Interval
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of Participants Who Completed All Study Visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in scores on the Perceived Stress Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in scores on the Perinatal Anxiety Screening Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Composite Pain Rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of relieving obstruction after stent insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Stoma rate in the two groups of patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of Participants meeting ACR 20 criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of repeated attempts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time-to-Relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rating of sensory attributes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PSA antibody levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glucose Prediction error
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Participants With Erlotinib Associated Rash at Week 2
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Erlotinib Associated Rash at Week 4
Endpoint domain: Adverse events/effects
Primary endpoint: Renal oxygen consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Area under the serum insulin aspart concentration-time curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: First Adjudicated Clinical Failure (CF) Event
Endpoint domain: Mortality/survival
Primary endpoint: Hospitalisation for Worsening PAH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants dead
Endpoint domain: Mortality/survival
Primary endpoint: Number of patients with lymph nodes metastasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Psychological tests
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prevalence of Severe Combined Immunodeficiency (SCID)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rates of participant retention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rates of questionnaire completion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in concentration of glutathione in brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Knee Pain Intensity Measured by Numeric Rating Scale (NRS) at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Knee Pain Intensity Measured by Visual Analog Scale (VAS) at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Western Ontario and McMaster (WOMAC) Osteoarthritis Index Pain Subscale Score at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Psychological Stress Measure-9 (PSM-9) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total correct responses
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Neurodevelopmental impairment at 2 years corrected age
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from baseline in FVC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Far Transfer of Surgical Skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Reduction in Intraocular Pressure (IOP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Benefit Rate (CBR)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Physical activity adoption and adherence
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Size of biopsy specimen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Architectural preservation of the airways/alveoli
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation of hot flash frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional assessment of the shoulder (Constant score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of patients with serious toxicity during cycle 1-2
Endpoint domain: Adverse events/effects
Primary endpoint: Metabolic CR rate (PET-diagnostic CT) after the third cycle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of CTCAE grade 3/4 non-hematological toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Tablet dissolution in oesophagus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rate of Revision for Aseptic Loosening or Device-related Femoral Fracture
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of screen time
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: C-reactive Protein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bioavailable Testosterone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Serum Hormone Binding Globulin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: duration of total 3D virtual treatment planning time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of spontaneous delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Change in urine albumin excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Relative IgG level in the blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Occurrence of spontaneous abortion
Endpoint domain: Mortality/survival
Primary endpoint: Unmet physical functioning needs
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Rate of right radial artery occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change in the anatomic progression of aortic stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Agreement in energy and nutrient reporting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of timely and complete vaccine uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depression Symptom Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in Menstrual Bleeding (PBLAC Score of ≤75)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Device or Procedure-related Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Patient pain and disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: International Index of Erectile Function (IIEF)
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Mean Breaking Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Breaking Force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: alterations in vital signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes